Joe Collier (clinical pharmacologist)

Last updated

Joe Collier

FRCP
Born
Joseph Gavin Collier [1]

1942 (age 81–82)
England
Education
Known for
SpouseRohan
Scientific career
Fields Clinical pharmacology
Website Official website

Joseph Gavin Collier FRCP (born 1942) is a British retired clinical pharmacologist and emeritus professor of medicines policy at St George's Hospital and Medical School in London, whose early research included establishing the effect of aspirin on human prostaglandins and looking at the role of nitric oxide and angiotensin converting enzyme in controlling blood vessel tone and blood pressure. Later, in his national policy work, he helped change the way drugs are priced and bought by the NHS, and ensured that members of governmental advisory committees published their conflicts of interest.

Contents

In 1986 he became a whistleblower when he revealed to the Commission for Racial Equality that software used for medical-school admissions selection at St George's was intentionally discriminating against women and ethnic minorities, by creating a lower score for women and those with non-European names so reducing their chance of being called for interview. Initially shunned within the institution, he was publicly thanked several years later for bringing the procedure to its attention. His work led to reviews of admissions policy to institutes of higher education throughout the UK.

He was editor of the Drug and Therapeutics Bulletin from 1992 to 2004, president of the International Society of Drug Bulletins from 2002 to 2005 and was a former member of the UK Medicines Commission from 1998.

Early life and education

Joseph Gavin Collier [1] was born to pharmacologist Henry Oswald Jackson Collier and actress Patience Collier. They also had two daughters, who later became the textile designers Sarah Campbell and Susan Collier. [2] [3]

After attending Cambridge, Collier gained admission to St George's Medical School in London to study medicine in 1964 and graduated in 1968. [1] He gained a MD in 1975. [1]

Career

Collier's career at St George's continued until his retirement in 2007. [4] [5] He was the school's first clinical pharmacologist and in 1998 was appointed professor of medicines policy. [6] [7] Amongst the lecturers he supervised were David Webb, [4] Sir Patrick Vallance, [8] [9] and Emma Baker. [10]

Research

Royal College of Surgeons of England, where Collier did his early research Royal College of Surgeons of England 1.jpg
Royal College of Surgeons of England, where Collier did his early research

He interspersed his junior medical training with two days a week at a laboratory situated in the Royal College of Surgeons in Lincoln's Inn Fields, run by John Vane. [11] In 1969, Collier confirmed, with Dornhorst, Lands' findings of β1-receptors in the heart and β2-receptors in the airways, in humans, [12] [13] and "suggested that the respiratory stimulation produced in man by β-receptor stimulants is a β1-action and is not linked with bronchodilatation." [14] In 1971, he co-authored a paper with Rod Flower showing that therapeutic doses of aspirin reduced prostaglandin E and F in human semen. [15] [16]

His early research included looking at the veins of the back of the hand, [17] and the behaviour of human peripheral blood vessels, being first to develop methods for studying how human veins respond to drugs and natural mediators in vivo and developed the idea that human veins and arterioles have very different pharmacologies. Through this work he classified vasoactive drugs as veno-selective, arteriolar-selective or non-selective, and that depending on their selectivity they would have different effects in disease. [18] [19] [20]

He later looked at the role of nitric oxide and angiotensin converting enzyme in controlling blood vessel tone. In 1987, he set out with Patrick Vallance to investigate whether human blood vessels demonstrated endothelium-dependent relaxation, a term coined in 1980 by Robert F. Furchgott and John V. Zawadzki after discovering that a large blood vessel would not relax when its single-layered inner most lining was removed. They subsequently showed that the occurrence was mediated by what they called endothelium-derived relaxing factor, later found to be nitric oxide, and it was subsequently shown to occur in a variety of animals. Using veins from the back of a human hand, Collier and his team reproduced Furchgott and Zawadzki's findings. [9] They then demonstrated that the human arterial vasculature is actively dilated by a continuous release of nitric oxide. [21] In 1996, Vallance presented his and Collier's findings at the Goulstonian Lecture of the Royal College of Physicians, where he gave details of the connection between nitric oxide and blood pressure. [22]

Commission for Racial Equality

Collier became a whistleblower in 1986 when, following his report published jointly with psychiatrist A. W. Burke, he informed the Commission for Racial Equality (CRE) that software used for medical-school admissions selection at St George's had been developed to intentionally discriminate against women and ethnic minorities, by mimicking methods of previous admissions officers. [23] [24] It was creating a lower score for women and those with non-European (Asian, African and Arabic) names so reducing their chance of being called for interview. [25] [26] [27]

Collier's findings led to an enquiry, both internal by St. George's and external by the CRE, and a subsequent report was published entitled Medical School Admissions: Report of a formal investigation into St. George's Hospital Medical School (1988). Like Collier and Burke, the report also raised the question of what might be happening in other London medical schools; St. George's already had a higher than average intake of students with non-European names. [24] [28] Collier was initially shunned within the institution and denied a due professorship. As attitudes changed, his position improved; he was promoted to professor and eventually the medical school publicly thanked him. [25] [24] [29] He discussed his experience in an article in the British Medical Journal in 1999 when he recalled that he "was ostracised, became invisible, told I [he] had brought the organisation into disrepute”. [29] [30] Changes in admissions procedures to institutes of higher education have since been made throughout the UK and Collier has since been acknowledged for contributing towards greater equality in recruitment practices. [29] [31]

National policy

In his national policy work, he raised awareness of how drugs are priced, brought to the market and regulated, in addition to how they are evaluated, licensed and promoted, and how drug safety advice is produced and revised. [7] He has spoken of the "excesses of industry", despite several general practitioners finding the pharmaceutical educational material they received as useful. [32]

In 1993, he was appointed lead adviser on medicines to Parliament's Health Select Committee. In 1998, he was appointed to the Medicines Commission. [7] He was one of the specialist scientific advisors who helped change the way drugs are priced and bought by the NHS. In 2007, Collier contributed to the report by the Office of Fair Trading, which recommended that drug prices to the NHS should be in accordance with their clinical value. [33] In addition, he worked to ensure that members of governmental advisory committees published their conflicts of interest. [34] [35]

Drug and Therapeutics Bulletin

Collier began working for the Drug and Therapeutics Bulletin (DTB) in 1969. In 1972, he became its deputy editor and member of the DTB's Advisory Council, after at first being associate editor. He succeeded Andrew Herxheimer, who founded the bulletin, as its editor in 1992, and over the following 12 years shaped the bulletin in response to new challenges of the time, including the growth in electronic information, evidence-based guidelines, a growing demand to engage the public and healthcare workers and the establishment of the National Institute for Clinical Excellence (NICE). [7] [36] [37]

Drug safety

In 1985, he complained to the Association of the British Pharmaceutical Industry that of 28 drug advertisements in the November 1985 issue of the British Medical Journal, 11 were in breach of the Medicines Act of 1968. [38]

Known to frequently question evidence and arguments accepted by others, under his editorship in 1998, the DTB opposed the Department of Health's view and supported the provision of sildenafil on the NHS. [7]

He later suggested that people should contribute to treatment agreements by signing their own prescriptions. [39]

With regards to off-label prescribing of drugs for children, Collier argued that “the validity of such an approach is questionable because there are such great differences between adults and children, and even between children of different ages, with regard for instance to the pharmacodynamic and pharmacokinetic responses to drugs, […], and the effects of drugs on normal growth and development”. [40]

Other roles

Collier is a Fellow of the Royal College of Physicians. He was elected president of the International Society of Drug Bulletins in 2002 and is a former member of the British Medicines Commission. [5] [7]

Personal and family

In 1965, Collier met French philosophy student, Rohan. [41] They married in 1968 and had three sons, the eldest of who died suddenly in 2013. They have one grandchild. Following retirement Collier has become an active blogger and fluent in French. [5] [10]

Awards and honours

In 2002, a walnut sculpture by Elona Bennett of several hands, including Collier's, was unveiled at St. George's. Titled "Handing on Skills, Ideas and Ideals", his hands feature alongside those of other people, including Edward Jenner and John Hunter. [42]

Selected publications

Papers

Books

Related Research Articles

<span class="mw-page-title-main">Hypnotic</span> Drug whose use induces sleep

Hypnotic, or soporific drugs, commonly known as sleeping pills, are a class of psychoactive drugs whose primary function is to induce sleep and to treat insomnia (sleeplessness).

In a blind or blinded experiment, information which may influence the participants of the experiment is withheld until after the experiment is complete. Good blinding can reduce or eliminate experimental biases that arise from a participants' expectations, observer's effect on the participants, observer bias, confirmation bias, and other sources. A blind can be imposed on any participant of an experiment, including subjects, researchers, technicians, data analysts, and evaluators. In some cases, while blinding would be useful, it is impossible or unethical. For example, it is not possible to blind a patient to their treatment in a physical therapy intervention. A good clinical protocol ensures that blinding is as effective as possible within ethical and practical constraints.

<span class="mw-page-title-main">Nitrazepam</span> Benzodiazepine sedative

Nitrazepam, sold under the brand name Mogadon among others, is a hypnotic drug of the benzodiazepine class used for short-term relief from severe, disabling anxiety and insomnia. It also has sedative (calming) properties, as well as amnestic, anticonvulsant, and skeletal muscle relaxant effects.

<span class="mw-page-title-main">Kamran Abbasi</span> British physician and sports writer

Kamran Abbasi is the editor-in-chief of the British Medical Journal (BMJ), a physician, visiting professor at the Department of Primary Care and Public Health, Imperial College, London, editor of the Journal of the Royal Society of Medicine(JRSM), journalist, cricket writer and broadcaster, who contributed to the expansion of international editions of the BMJ and has argued that medicine cannot exist in a political void.

<span class="mw-page-title-main">Lauder Brunton</span> British physician (1844–1916)

Sir Thomas Lauder Brunton, 1st Baronet, was a British physician who is most-closely associated with the use of amyl nitrite to treat angina pectoris.

<span class="mw-page-title-main">Benzodiazepine overdose</span> Medical condition

Benzodiazepine overdose describes the ingestion of one of the drugs in the benzodiazepine class in quantities greater than are recommended or generally practiced. The most common symptoms of overdose include central nervous system (CNS) depression, impaired balance, ataxia, and slurred speech. Severe symptoms include coma and respiratory depression. Supportive care is the mainstay of treatment of benzodiazepine overdose. There is an antidote, flumazenil, but its use is controversial.

The Goulstonian Lectures are an annual lecture series given on behalf of the Royal College of Physicians in London. They began in 1639. The lectures are named for Theodore Goulston, who founded them with a bequest. By his will, dated 26 April 1632, he left £200 to the College of Physicians of London to found a lectureship, to be held in each year by one of the four youngest doctors of the college. These lectures were annually delivered from 1639, and have continued for more than three centuries. Up to the end of the 19th century, the spelling Gulstonian was often used. In many cases the lectures have been published.

<span class="mw-page-title-main">Lumleian Lectures</span>

The Lumleian Lectures are a series of annual lectures started in 1582 by the Royal College of Physicians and currently run by the Lumleian Trust. The name commemorates John Lumley, 1st Baron Lumley, who with Richard Caldwell of the College endowed the lectures, initially confined to surgery, but now on general medicine. William Harvey did not announce his work on the circulation of the blood in the Lumleian Lecture for 1616 although he had some partial notes on the heart and blood which led to the discovery of the circulation ten years later. By that time ambitious plans for a full anatomy course based on weekly lectures had been scaled back to a lecture three times a year.

<span class="mw-page-title-main">Andrew Haines</span>

Sir Andrew Paul Haines, FMedSci is a British epidemiologist and academic. He was the Director of the London School of Hygiene & Tropical Medicine from 2001 to 2010.

The Bradshaw Lectures are lectureships given at the invitation of the Royal College of Physicians and the Royal College of Surgeons of England. It is held on alternate years in rotation with the Hunterian Oration.

Malcolm VandenBurg is a British doctor involved in drug research, sexual health, medicolegal advice and stress management.

The Cameron Prize for Therapeutics of the University of Edinburgh is awarded by the College of Medicine and Veterinary Medicine to a person who has made any highly important and valuable addition to Practical Therapeutics in the previous five years. The prize, which may be awarded biennially, was founded in 1878 by Andrew Robertson Cameron of Richmond, New South Wales, with a sum of £2,000. The University's senatus academicus may require the prizewinner to deliver one or more lectures or to publish an account on the addition made to Practical Therapeutics. A list of recipients of the prize dates back to 1879.

Professor Miles Weatherall (1920-2007) was a British pharmacologist.

<span class="mw-page-title-main">Patrick Vallance</span> British medical doctor

Sir Patrick John Thompson Vallance is a British physician, scientist, and clinical pharmacologist who has worked in both academia and industry. He served as the Chief Scientific Adviser to the Government of the United Kingdom from 2018 to 2023. On stepping down, he became chair of the Natural History Museum in London.

Una Martin is an emeritus professor of clinical pharmacology and was formerly the deputy pro-vice chancellor for equalities at the University of Birmingham. She is an expert in hypertension and ambulatory monitoring. She is a Fellow of the British Pharmacological Society.

Azeem Majeed is a Professor and Head of the Department of Primary Care & Public Health at Imperial College, London, as well as a general practitioner in South London and a consultant in public health. In the most recent UK University Research Excellence Framework results, Imperial College London was the highest ranked university in the UK for the quality of research in the “Public Health, Health Services and Primary Care” unit of assessment.

Emma Harriet Baker is a British professor of clinical pharmacology and consultant physician in internal medicine at St George's Hospital, London. She has a specialist interest in people who have multiple medical conditions at the same time and take several medications, with a particular focus on lung disease. She is director of the UK's first BSc in clinical pharmacology, clinical vice president of the British Pharmacological Society and training programme director at Health Education England.

<span class="mw-page-title-main">Thomas King Chambers</span>

Thomas King Chambers was an English physician who published and lectured on diet and digestion. He was among the first to advocate medicine as a career for women. He was a founder and trustee of the London School of Medicine for Women.

Robert James Lee was an English physician. He published papers on diseases of children and on the "treatment of pulmonary phthisis by antiseptic vapours".

References

  1. 1 2 3 4 Medical Directory. Churchill Livingstone. 1999. p. 1975. ISBN   978-1-86067-394-8.
  2. ↑ Levy, Paul (30 June 2011). "Susan Collier: Award-winning textile designer best known for her work for Liberty and Habitat" . The Independent. Archived from the original on 9 June 2022. Retrieved 19 June 2020.
  3. ↑ "Dr H.O.J. Collier: Obituary". British Journal of Pharmacology. 81 (1): 11–12. January 1984. doi:10.1111/j.1476-5381.1984.tb10734.x. ISSN   0007-1188. PMC   1986965 .
  4. 1 2 Reynolds, L. A.; Tansey, E. M., eds. (2008). Clinical Pharmacology in the UK, c. 1950–2000: Industry and Regulation (PDF). Wellcome Witnesses to Twentieth Century Medicine. Vol. 34. London: Wellcome Trust Centre for the History of Medicine at UCL. p. 90. ISBN   978-085484-118-9.
  5. 1 2 3 Goodwin, C. (12 July 2003). "Joe Collier". The Lancet. 362 (9378): 178. doi:10.1016/S0140-6736(03)13888-3. ISSN   0140-6736. PMID   12867137. S2CID   54395292.
  6. ↑ "History — Welcome to the Clinical Pharmacology and Therapeutics Unit". St George's, University of London. Retrieved 29 June 2017.
  7. 1 2 3 4 5 6 "Joe Collier's editorship of DTB" . Drug and Therapeutics Bulletin. 42 (6): 47–48. 1 June 2004. doi:10.1136/dtb.2004.42647. ISSN   0012-6543. S2CID   220171305 – via BMJ Publishing Group.
  8. ↑ Anon (2015). "Patrick Vallance: Inquisitive and geeky". British Medical Journal . 350 (mar05 5): h1144. doi:10.1136/bmj.h1144. ISSN   1756-1833. PMID   25742697. S2CID   5081180.(subscription required)
  9. 1 2 Blackman Daniel J.; Morris-Thurgood Jayne A.; Atherton John J.; Ellis Gethin R.; Anderson Richard A.; Cockcroft John R.; Frenneaux Michael P. (2000). "Endothelium-Derived Nitric Oxide Contributes to the Regulation of Venous Tone in Humans". Circulation. 101 (2): 165–170. doi: 10.1161/01.CIR.101.2.165 . PMID   10637204.
  10. 1 2 Collier, Joe. "The Joe Collier Blog". The Joe Collier Blog. Retrieved 25 June 2020.
  11. ↑ Jeffreys, Diarmuid (2005). Aspirin: The Remarkable Story of a Wonder Drug. New York: Bloomsbury. pp. 226–231. ISBN   1-58234-386-1.
  12. ↑ Barnes, Peter J. (2006). "Drugs for asthma". British Journal of Pharmacology. 147 (S1): S297–S303. doi:10.1038/sj.bjp.0706437. ISSN   1476-5381. PMC   1760737 . PMID   16402117.
  13. ↑ Arnold, A. (2012). "2. Sympathomimetic Amine Induced responses of Effector Organs subserved by Alpha-, Beta1 and Beta2 Adrenoceptors". In L. Szekeres (ed.). Adrenergic Activators and Inhibitors: Part I. Vol. Part 1. Springer-Verlag. p. 72. ISBN   978-3-642-67507-2.
  14. ↑ Collier, J. G.; Dornhorst, A. C. (September 1969). "Evidence for Two Different Types of βReceptors in Man". Nature. 223 (5212): 1283–1284. Bibcode:1969Natur.223.1283C. doi:10.1038/2231283a0. ISSN   1476-4687. PMID   5807006. S2CID   4298944.
  15. ↑ Craig, Gillian M. (February 1975). "Prostaglandins in reproductive physiology". Postgraduate Medical Journal. 51 (592): 74–84. doi:10.1136/pgmj.51.592.74. ISSN   0032-5473. PMC   2495714 . PMID   1089972.
  16. ↑ Flower, Rod (2012). "9. The Discovery of Prostaglandins". In Thompson, Gilbert R. (ed.). Nobel Prizes That Changed Medicine. Imperial College Press. p. 187. ISBN   978-1-84816-826-8.
  17. ↑ Aellig, W. H. (1994). "Clinical pharmacology, physiology and pathophysiology of superficial veins-2". British Journal of Clinical Pharmacology. 38 (4): 289–305. doi:10.1111/j.1365-2125.1994.tb04357.x. ISSN   1365-2125. PMC   1364771 . PMID   7833218.
  18. ↑ Robinson, B. F. (1981). "Drugs acting directly on vascular smooth muscle". British Journal of Clinical Pharmacology. 12 (Suppl 1): 5S–9S. doi:10.1111/j.1365-2125.1981.tb00288.x. ISSN   0306-5251. PMC   1401728 .
  19. ↑ Roddie, I. C.; Wallace, W. F. M. (2012). "6. Peripheral CirculationI". In U. Abshagen (ed.). Clinical Pharmacology of Antianginal Drugs. Springer Verlag. p. 174. ISBN   978-3-642-69526-1.
  20. ↑ Aellig, W. H. (1981). "A new technique for recording compliance of human hand veins". British Journal of Clinical Pharmacology. 11 (3): 237–243. doi:10.1111/j.1365-2125.1981.tb00527.x. ISSN   1365-2125. PMC   1401623 . PMID   7213525.
  21. ↑ Barba, Gianvincenzo; Mullen, Michael J.; Donald, Anne; MacAllister, Raymond J. (1999). "Determinants of the Response of Human Blood Vessels to Nitric Oxide Donors In Vivo". Journal of Pharmacology and Experimental Therapeutics. 289 (3): 1662–1668. ISSN   0022-3565. PMID   10336566.
  22. ↑ Vallance, Patrick (1997). "Exploring vascular nitric oxide in health and disease. The Goulstonian Lecture 1996". Journal of the Royal College of Physicians of London. 31 (3): 321–7. PMC   5421009 . PMID   9192338.
  23. ↑ "2. The Commission's Findings". Medical School Admissions: Report of a Formal Investigation Into St. George's Hospital Medical School. Commission for Racial Equality. 1988. pp. 12–13. ISBN   978-0-907920-94-6.
  24. 1 2 3 Lowry, Stella; Macpherson, Gordon (5 March 1988). "A blot on the profession". British Medical Journal. 296 (6623): 657–658. doi:10.1136/bmj.296.6623.657. PMC   2545288 . PMID   3128356.
  25. 1 2 Cassidy, Jane (1 August 2009). "Name and Shame" (PDF). British Medical Journal . 339: 267. doi:10.1136/bmj.b2693. PMID   19633039. S2CID   6830670.
  26. ↑ Paul Iganski; David Mason (2018). Ethnicity, Equality of Opportunity and the British National Health Service. Routledge. pp. 135–. ISBN   978-1-138-72873-8.
  27. ↑ Morrison, Lionel (24 February 1988). "CRE investigation finds discrimination in medical school admissions". Commission for Racial Equality (Press release). London.
  28. ↑ "Introduction". Medical School Admissions: Report of a Formal Investigation Into St. George's Hospital Medical School. Commission for Racial Equality. 1988. p. 5. ISBN   978-0-907920-94-6.
  29. 1 2 3 "Error and institutionalised racism". British Medical Journal. 318 (7184): 0. 6 March 1999. ISSN   0959-8138. PMC   1115062 .
  30. ↑ Collier, Joe (1999). "Tackling Institutional Racism". BMJ: British Medical Journal. 318 (7184): 679. doi:10.1136/bmj.318.7184.679. ISSN   0959-8138. JSTOR   25183954. PMC   1115118 . PMID   10066235.
  31. ↑ Sheikh, Aziz (October 2001). "What's to be done about racism in medicine?". Journal of the Royal Society of Medicine . 94 (10): 499–500. doi:10.1177/014107680109401001. ISSN   0141-0768. PMC   1282200 . PMID   11581340.
  32. ↑ Sullivan, Thomas (11 February 2009). "Royal College of Physicians: UK Report on Industry Relationships". www.policymed.com. Retrieved 21 June 2020.
  33. ↑ Great Britain: Parliament: House of Commons: Health Committee (2008). "Introduction". National Institute for Health and Clinical Excellence: first report of session 2007-08, Vol. 1: Report, together with formal minutes. Vol. 1. The Stationery Office. p. 10. ISBN   978-0-215-03796-1.
  34. ↑ Spencer, J A; van Zwanenberg, T D (July 1989). "Prescribing research: PACT to the future". The Journal of the Royal College of General Practitioners. 39 (324): 270–272. ISSN   0035-8797. PMC   1711886 . PMID   2556539.
  35. ↑ Collier, J. (17 August 1985). "Licensing and provision of medicines in the United Kingdom. An appraisal". Lancet. 2 (8451): 377–381. ISSN   0140-6736. PMID   2862524.
  36. ↑ "2. The NHS". Clinical Pharmacology and Therapeutics in a Changing World: Report of a Working Party. London: Royal College of Physicians. 1999. p. 8. ISBN   1-860160891.
  37. ↑ Lyall, Joanna (15 March 2016). "Andrew Herxheimer (1925–2016)". The Pharmaceutical Journal. Archived from the original on 1 April 2021.
  38. ↑ Lesser, Frank (2 May 1985). New Scientist. Reed Business Information. p. 8.
  39. ↑ Chen, Judy (6 March 1999). ""Medication concordance" is best helped by improving consultation skills". BMJ: British Medical Journal. 318 (7184): 670–1. doi:10.1136/bmj.318.7184.670. ISSN   0959-8138. PMC   1115106 . PMID   10066223.
  40. ↑ Lenk, Christian; Koch, Philipp; Zappel, Hildegard; Wiesemann, Claudia (December 2009). "Off-label, off-limits? Parental awareness and attitudes towards off-label use in paediatrics". European Journal of Pediatrics. 168 (12): 1473–1478. doi:10.1007/s00431-009-0956-6. ISSN   0340-6199. PMC   2772947 . PMID   19277709.
  41. ↑ Collier, Joe (2020). "A mysterious man in the waiting room". As I See It: Further Reflections on Everyday Life. London Press. p. 109. ISBN   978-1-905006-68-7.
  42. ↑ Ferriman, Annabel (7 December 2002). "Sculpture symbolises passing on of clinical skills". British Medical Journal . 325 (7376): 1322. doi:10.1136/bmj.325.7376.1322. ISSN   0959-8138. PMC   1124800 . PMID   12468475.

Further reading

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.